Eurofins to offer biopharma testing in Japan with Astellas lab deal

By Flora Southey contact

- Last updated on GMT

Getty/Laurent Watanabe
Getty/Laurent Watanabe
Astellas will contract out an internal testing laboratory to Eurofins Scientific, marking the CRO’s entry into biopharmaceutical product testing in Japan.

Contract research organisation (CRO) Eurofins has signed an outsourcing agreement with Japanese pharmaceutical company Astellas for one of its testing laboratories in Kyoto.

Astellas’ Analytical Science Laboratories (ASL) offers testing services for raw materials and drug substances, as well as quality evaluation, test method validation, and physicochemical testing.

The laboratory also tests cell based assay for antibodies, offering Eurofins entry into the biopharmaceutical products testing market in Japan.

According to the agreement, Astellas will provide ASL work for “an agreed period of time” ​while Eurofins invests in capabilities and adds staff to the current 140-member workforce.

Eurofins is committed to serving Astellas and its “expanding group of clients in the APAC region,” ​CEO Gilles Martin said in a statement.

The CRO declined a request for additional comment.

The Astellas deal marks Luxembourg-headquartered Eurofins’ latest expansion into the global market. In 2016, the CRO acquired US analytical services firm Advantar Laboratories​, Australian QC company ams​, and Dutch QC services firm Sinensis Life Science.

Last year, the firm bought Canadian drug ingredient manufacturer and testing contractor Alphora Research​ and India-based preclinical CRO Advinus Therapeutics​. And in January this year, Eurofins announced plans to buy UK CRO Selcia​.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars